Literature DB >> 22129994

Increased transmission and outbreaks of measles--European Region, 2011.

.   

Abstract

During 2003-2009, substantial progress was made toward the previous goal of measles elimination in the World Health Organization (WHO) European Region (EUR) by 2010. However, since late 2009, measles virus transmission has increased, and outbreaks have become widespread. In 2011, measles outbreaks have been reported in 36 of 53 EUR member states; a total of 26,074 measles cases had been reported regionwide as of October 26. France reported the largest number of cases (approximately 14,000), predominantly among older children and young adults who had not been vaccinated or whose vaccination history was unknown. Overall, the primary reason for the increased transmission and outbreaks of measles in EUR is failure to vaccinate susceptible populations. Eliminating measles by 2015, a new measles elimination target date set in September 2010 by the 60th Regional Committee for Europe, will require 1) increasing demand for and delivery of vaccination to achieve and sustain ≥ 95% coverage with 2 doses of measles-containing vaccine (MCV) across a wide age range, 2) implementing effective outbreak control measures, and 3) further strengthening surveillance to identify cases and outbreaks promptly, and in the future, to validate elimination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22129994

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  28 in total

Review 1.  Vaccination of healthcare workers: A review.

Authors:  Skerdi Haviari; Thomas Bénet; Mitra Saadatian-Elahi; Philippe André; Pierre Loulergue; Philippe Vanhems
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Comparative evaluation of a new chemiluminiscent assay and an ELISA for the detection of IgM against measles.

Authors:  Antonio Sampedro; Javier Rodríguez-Granger; Cristina Gómez; Ana Lara; José Gutierrez; Ana Otero
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

3.  International Importations of Measles Virus into the United States During the Postelimination Era, 2001-2016.

Authors:  Adria D Lee; Nakia S Clemmons; Manisha Patel; Paul A Gastañaduy
Journal:  J Infect Dis       Date:  2019-04-19       Impact factor: 5.226

4.  Face up to challenge of virology world.

Authors:  Xiaoli Lilly Pang
Journal:  World J Virol       Date:  2012-02-12

5.  Knowledge and risk perception of measles and factors associated with vaccination decisions in subjects consulting university affiliated public hospitals in Lyon, France, after measles infection.

Authors:  Abdoulaye Toure; Mitra Saadatian-Elahi; Daniel Floret; Bruno Lina; Jean-Sebastien Casalegno; Philippe Vanhems
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

6.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

7.  HHS--supporting global immunization through policies, programs, and partnerships.

Authors:  Nils Daulaire
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

8.  Childhood Vaccine Exemption Policy: The Case for a Less Restrictive Alternative.

Authors:  Douglas J Opel; Matthew P Kronman; Douglas S Diekema; Edgar K Marcuse; Jeffrey S Duchin; Eric Kodish
Journal:  Pediatrics       Date:  2016-03-18       Impact factor: 7.124

9.  The Economic Value of Vaccination: Why Prevention is Wealth.

Authors: 
Journal:  J Mark Access Health Policy       Date:  2015-08-12

10.  GeoSentinel surveillance of illness in returned travelers, 2007-2011.

Authors:  Karin Leder; Joseph Torresi; Michael D Libman; Jakob P Cramer; Francesco Castelli; Patricia Schlagenhauf; Annelies Wilder-Smith; Mary E Wilson; Jay S Keystone; Eli Schwartz; Elizabeth D Barnett; Frank von Sonnenburg; John S Brownstein; Allen C Cheng; Mark J Sotir; Douglas H Esposito; David O Freedman
Journal:  Ann Intern Med       Date:  2013-03-19       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.